180 related articles for article (PubMed ID: 28440605)
1. [Carbapenem resistance in Pseudomonas aeruginosa isolated from urine cultures: prevalence and risk factors].
Álvarez-Otero J; Lamas-Ferreiro JL; González-González L; Rodríguez-Conde I; Fernández-Soneira MJ; Arca-Blanco A; Bermúdez-Sanjurjo JR; de la Fuente-Aguado J
Rev Esp Quimioter; 2017 Jun; 30(3):183-194. PubMed ID: 28440605
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ
J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
Lin KY; Lauderdale TL; Wang JT; Chang SC
J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y
J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients.
Pettigrew MM; Gent JF; Kong Y; Halpin AL; Pineles L; Harris AD; Johnson JK
Clin Infect Dis; 2019 Aug; 69(4):604-613. PubMed ID: 30383203
[TBL] [Abstract][Full Text] [Related]
7. In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
Ma W; Li J; Wang D; Yu C; Sun S
Lett Appl Microbiol; 2019 Sep; 69(3):198-203. PubMed ID: 31236975
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa].
Cekin Y; Karagöz A; Kızılateş F; Cekin AH; Oztoprak Çuvalcı N; Bülbüller N; Durmaz R
Mikrobiyol Bul; 2013 Oct; 47(4):619-27. PubMed ID: 24237430
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
10. Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis.
Liu Q; Li X; Li W; Du X; He JQ; Tao C; Feng Y
Sci Rep; 2015 Jun; 5():11715. PubMed ID: 26108476
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Pseudomonas aeruginosa isolates from patients with urinary tract infections during antibiotic therapy.
Horii T; Muramatsu H; Morita M; Maekawa M
Microb Drug Resist; 2003; 9(2):223-9. PubMed ID: 12820809
[TBL] [Abstract][Full Text] [Related]
12. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.
Coppry M; Jeanne-Leroyer C; Noize P; Dumartin C; Boyer A; Bertrand X; Dubois V; Rogues AM
J Antimicrob Chemother; 2019 Feb; 74(2):503-510. PubMed ID: 30376042
[TBL] [Abstract][Full Text] [Related]
14. Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.
Walters MS; Grass JE; Bulens SN; Hancock EB; Phipps EC; Muleta D; Mounsey J; Kainer MA; Concannon C; Dumyati G; Bower C; Jacob J; Cassidy PM; Beldavs Z; Culbreath K; Phillips WE; Hardy DJ; Vargas RL; Oethinger M; Ansari U; Stanton R; Albrecht V; Halpin AL; Karlsson M; Rasheed JK; Kallen A
Emerg Infect Dis; 2019 Jul; 25(7):1281-1288. PubMed ID: 31211681
[TBL] [Abstract][Full Text] [Related]
15. The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis.
Chen Z; Xu Z; Wu H; Chen L; Gao S; Chen Y
Am J Infect Control; 2019 Jun; 47(6):677-682. PubMed ID: 30554879
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors for Pseudomonas aeruginosa infections, resistant to carbapenem].
Ghibu L; Miftode E; Teodor A; Bejan C; Dorobăţ CM
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1012-6. PubMed ID: 21500452
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran.
Heidari R; Farajzadeh Sheikh A; Hashemzadeh M; Farshadzadeh Z; Salmanzadeh S; Saki M
Mol Biol Rep; 2022 May; 49(5):3811-3822. PubMed ID: 35169997
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
Tam VH; Chang KT; LaRocco MT; Schilling AN; McCauley SK; Poole K; Garey KW
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem-resistant
Huang W; Wei X; Xu G; Zhang X; Wang X
Front Public Health; 2023; 11():1088262. PubMed ID: 36844819
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for carbapenem-nonsusceptible Pseudomonas aeruginosa: Case-control study.
Khadem T; Stevens V; Holt K; Hoffmann C; Dumyati G; Brown J
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):146-150. PubMed ID: 28780998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
